Ridgeback Capital's book
6 companies · priced for members| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | ▮ | ▮ | ▮ | ▮ |
| Crisp | — | ▮ | ▮ | ▮ | ▮ |
| Arbor Biotechnologies | — | ▮ | ▮ | ▮ | ▮ |
+ 3 more companies · all 6, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | |||||
Ridgeback Capital portfolio at a glance
6 portfolio companies are on record for Ridgeback Capital, including Freenome, Crisp and Arbor Biotechnologies. The book leans Decision/Risk Analysis (1) and Drug Discovery (1).
6 of the 6 carry a recorded valuation.
Free account
See more of the book
- ·The top 10 names in the book — of 6 recorded positions
- ·Watchlist + alerts for Ridgeback Capital's activity